Neopterin and alpha-interferon in patients affected by Kaposi's sarcoma from Africa
- 1 August 1989
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 25 (8) , 1145-1150
- https://doi.org/10.1016/0277-5379(89)90407-0
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- DECLINES IN PROPORTION OF KAPOSI'S SARCOMA AMONG CASES OF AIDS IN MULTIPLE RISK GROUPS IN NEW YORK CITYThe Lancet, 1987
- CLINICAL CASE DEFINITION OF AIDS IN AFRICAN ADULTSThe Lancet, 1987
- ISOLATION OF HIV-1 FROM MONOCYTES BUT NOT T LYMPHOCYTESThe Lancet, 1987
- Pathogenesis of Infection with Human Immunodeficiency VirusNew England Journal of Medicine, 1987
- Activation of monocyte-mediated tumoricidal activity in patients with acquired immunodeficiency syndrome.Journal of Clinical Oncology, 1985
- Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma.The Journal of Experimental Medicine, 1984
- Kaposi's Sarcoma: An Opportunistic NeoplasmJournal of Investigative Dermatology, 1984
- Urinary neopterin in the diagnosis of acquired immune deficiency syndromeEuropean Journal of Clinical Microbiology & Infectious Diseases, 1984
- Lymphokine enhances oxygen-independent activity against intracellular pathogens.The Journal of Experimental Medicine, 1983
- INTERFERON ASSAY AS A DIAGNOSTIC TESTThe Lancet, 1981